stem cells delay the progression of ALS

Transplanted bone marrow-derived endothelial stem cells delay the progression of ALS

According to a report, published by researchers from the University of South Florida on March 27, in Scientific Reports, transplantation of human bone marrow-derived endothelial progenitor cells (EPCs) into mice with similar symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier (BSCB).

Read More